Examining response to immunotherapy in clear-cell renal cell carcinoma using baseline serum metabolic signatures

被引：0
|
作者：
Pirhaji, Leila [1 ]
Morris, Matthew [1 ]
Eaton, Jonah [1 ]
Zhang, Min [1 ]
机构：
[1] ReviveMed Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2604
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Re: Sorafenib in advanced clear-cell renal cell carcinoma
    Karakiewicz, Pierre I.
    Hutterer, Georg
    EUROPEAN UROLOGY, 2007, 52 (01) : 279 - 280
  • [22] Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma
    Vuong, Lynda
    Kotecha, Ritesh R.
    Voss, Martin H.
    Hakimi, A. Ari
    CANCER DISCOVERY, 2019, 9 (10) : 1349 - 1357
  • [23] Obesity, Cholesterol, and Clear-Cell Renal Cell Carcinoma (RCC)
    Drabkin, Harry A.
    Gemmill, Robert M.
    ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 : 39 - 56
  • [24] Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase
    Kinnaird, Adam
    Dromparis, Peter
    Saleme, Bruno
    Gurtu, Vikram
    Watson, Kristalee
    Paulin, Roxane
    Zervopoulos, Sotirios
    Stenson, Trevor
    Sutendra, Gopinath
    Pink, Desmond B.
    Carmine-Simmen, Katia
    Moore, Ronald
    Lewis, John D.
    Michelakis, Evangelos D.
    EUROPEAN UROLOGY, 2016, 69 (04) : 734 - 744
  • [25] Integrated molecular analysis of clear-cell renal cell carcinoma
    Sato, Yusuke
    Yoshizato, Tetsuichi
    Shiraishi, Yuichi
    Maekawa, Shigekatsu
    Okuno, Yusuke
    Kamura, Takumi
    Shimamura, Teppei
    Sato-Otsubo, Aiko
    Nagae, Genta
    Suzuki, Hiromichi
    Nagata, Yasunobu
    Yoshida, Kenichi
    Kon, Ayana
    Suzuki, Yutaka
    Chiba, Kenichi
    Tanaka, Hiroko
    Niida, Atsushi
    Fujimoto, Akihiro
    Tsunoda, Tatsuhiko
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Sugano, Sumio
    Fukayama, Masashi
    Aburatani, Hiroyuki
    Sanada, Masashi
    Miyano, Satoru
    Homma, Yukio
    Ogawa, Seishi
    NATURE GENETICS, 2013, 45 (08) : 860 - U191
  • [26] Dystroglycan expression in clear-cell type renal cell carcinoma
    Camerini, A.
    De Luca, F.
    Genovese, G.
    De Paola, B.
    Valsuani, C.
    Tartarelli, G.
    Donati, S.
    Rettino, A.
    Cittadini, A.
    Sgambato, A.
    Gentili, C.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2006, 17 : XI34 - XI35
  • [27] Sorafenib in advanced clear-cell renal-cell carcinoma
    Escudier, Bernard
    Eisen, Tim
    Stadler, Walter M.
    Szczylik, Cezary
    Oudard, Stephane
    Siebels, Michael
    Negrier, Sylvie
    Chevreau, Christine
    Solska, Ewa
    Desai, Apurva A.
    Rolland, Frederic
    Demkow, Tomasz
    Hutson, Thomas E.
    Gore, Martin
    Freeman, Scott
    Schwartz, Brian
    Shan, Minghua
    Simantov, Ronit
    Bukowski, Ronald M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 125 - 134
  • [28] Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma
    Cui, Honglei
    Wu, Jie
    Du, Gan
    Hu, Linjun
    Dong, Xin
    Qu, Wang
    Bai, Hongsong
    Shang, Bingqing
    Xie, Ruiyang
    Shi, Hongzhe
    Guan, Youyan
    Bi, Xingang
    Li, Changling
    Ma, Jianhui
    Zhou, Aiping
    Shou, Jianzhong
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 70 : 109 - 115
  • [29] Proteomic signatures of clear cell renal cell carcinoma
    Chad J. Creighton
    Nature Reviews Nephrology, 2020, 16 : 133 - 134
  • [30] Is adjuvant immunotherapy worth for all patients with clear-cell renal cell carcinoma at high risk of recurrence?
    Campi, R.
    Amparore, D.
    Marandino, L.
    Bertolo, R.
    Erdem, S.
    Ingels, A.
    Muselaers, S.
    Pavan, N.
    Roussel, E.
    Carbonara, U.
    Pecoraro, A.
    Diana, P.
    Pecoraro, A.
    Marchioni, M.
    EUROPEAN UROLOGY, 2023, 83 : S676 - S677
12345